Ligand validation:5VYH

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5VYH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VYH_NAG_A_403	78%	80%	0.107	0.949	0.33	0.51	-	-	0	0	100%	0.9333
5VYH_NAG_A_406	28%	90%	0.189	0.842	0.27	0.35	-	-	0	0	100%	0.9333
5VYH_NAG_A_401	23%	87%	0.207	0.827	0.36	0.34	-	-	0	0	100%	0.9333
5VYH_NAG_A_407	19%	82%	0.262	0.857	0.23	0.56	-	-	0	0	100%	0.9333
5VYH_NAG_A_408	16%	91%	0.208	0.778	0.18	0.38	-	-	0	0	100%	0.9333
5VYH_NAG_A_404	13%	77%	0.309	0.852	0.4	0.5	-	-	0	0	100%	0.9333
5VYH_NAG_A_402	11%	73%	0.27	0.784	0.26	0.77	-	1	1	0	100%	0.9333
5VYH_NAG_A_405	1%	75%	0.47	0.652	0.47	0.5	-	-	1	0	100%	0.9333
6PXH_NAG_A_410	43%	86%	0.145	0.87	0.33	0.39	-	-	0	0	100%	0.9333
6J11_NAG_B_410	43%	40%	0.178	0.9	1.25	1.16	1	2	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.